COVID-19 Impact on Global General Anaesthesia Drugs Market Size, Status and Forecast 2020-2026
![](/report_cover/6975/covid-19-impact-on-global-general-anaesthesia-drugs-market-size-status-n-forecast-2020-2026_en.gif)
This report focuses on the global General Anaesthesia Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the General Anaesthesia Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
The key players covered in this study
- Baxter International
- AstraZeneca
- Abbott Laboratories
- Roche
- Fresenius
- Mylan
- Eisai
- Hospira
- Hikma Pharmaceuticals
- Propofol
- Sevoflurane
- Isoflurane
- Dexmedetomidine
- Desflurane
- Remifentanil
- Midazolam
- Others
- Hospitals
- Clinics
- Others
- North America
- Europe
- China
- Japan
- Southeast Asia
- India
- Central & South America
- To analyze global General Anaesthesia Drugs status, future forecast, growth opportunity, key market and key players.
- To present the General Anaesthesia Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
- To strategically profile the key players and comprehensively analyze their development plan and strategies.
- To define, describe and forecast the market by type, market and key regions.
- History Year: 2015-2019
- Base Year: 2019
- Estimated Year: 2020
- Forecast Year 2020 to 2026
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by General Anaesthesia Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global General Anaesthesia Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Propofol
1.4.3 Sevoflurane
1.4.4 Isoflurane
1.4.5 Dexmedetomidine
1.4.6 Desflurane
1.4.7 Remifentanil
1.4.8 Midazolam
1.4.9 Others
1.5 Market by Application
1.5.1 Global General Anaesthesia Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): General Anaesthesia Drugs Industry Impact
1.6.1 How the Covid-19 is Affecting the General Anaesthesia Drugs Industry
1.6.1.1 General Anaesthesia Drugs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and General Anaesthesia Drugs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for General Anaesthesia Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 General Anaesthesia Drugs Market Perspective (2015-2026)
2.2 General Anaesthesia Drugs Growth Trends by Regions
2.2.1 General Anaesthesia Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 General Anaesthesia Drugs Historic Market Share by Regions (2015-2020)
2.2.3 General Anaesthesia Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 General Anaesthesia Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key General Anaesthesia Drugs Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top General Anaesthesia Drugs Players by Market Size
3.1.1 Global Top General Anaesthesia Drugs Players by Revenue (2015-2020)
3.1.2 Global General Anaesthesia Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global General Anaesthesia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global General Anaesthesia Drugs Market Concentration Ratio
3.2.1 Global General Anaesthesia Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by General Anaesthesia Drugs Revenue in 2019
3.3 General Anaesthesia Drugs Key Players Head office and Area Served
3.4 Key Players General Anaesthesia Drugs Product Solution and Service
3.5 Date of Enter into General Anaesthesia Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global General Anaesthesia Drugs Historic Market Size by Type (2015-2020)
4.2 Global General Anaesthesia Drugs Forecasted Market Size by Type (2021-2026)
5 GENERAL ANAESTHESIA DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global General Anaesthesia Drugs Market Size by Application (2015-2020)
5.2 Global General Anaesthesia Drugs Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America General Anaesthesia Drugs Market Size (2015-2020)
6.2 General Anaesthesia Drugs Key Players in North America (2019-2020)
6.3 North America General Anaesthesia Drugs Market Size by Type (2015-2020)
6.4 North America General Anaesthesia Drugs Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe General Anaesthesia Drugs Market Size (2015-2020)
7.2 General Anaesthesia Drugs Key Players in Europe (2019-2020)
7.3 Europe General Anaesthesia Drugs Market Size by Type (2015-2020)
7.4 Europe General Anaesthesia Drugs Market Size by Application (2015-2020)
8 CHINA
8.1 China General Anaesthesia Drugs Market Size (2015-2020)
8.2 General Anaesthesia Drugs Key Players in China (2019-2020)
8.3 China General Anaesthesia Drugs Market Size by Type (2015-2020)
8.4 China General Anaesthesia Drugs Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan General Anaesthesia Drugs Market Size (2015-2020)
9.2 General Anaesthesia Drugs Key Players in Japan (2019-2020)
9.3 Japan General Anaesthesia Drugs Market Size by Type (2015-2020)
9.4 Japan General Anaesthesia Drugs Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia General Anaesthesia Drugs Market Size (2015-2020)
10.2 General Anaesthesia Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia General Anaesthesia Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia General Anaesthesia Drugs Market Size by Application (2015-2020)
11 INDIA
11.1 India General Anaesthesia Drugs Market Size (2015-2020)
11.2 General Anaesthesia Drugs Key Players in India (2019-2020)
11.3 India General Anaesthesia Drugs Market Size by Type (2015-2020)
11.4 India General Anaesthesia Drugs Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America General Anaesthesia Drugs Market Size (2015-2020)
12.2 General Anaesthesia Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America General Anaesthesia Drugs Market Size by Type (2015-2020)
12.4 Central & South America General Anaesthesia Drugs Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Baxter International
13.1.1 Baxter International Company Details
13.1.2 Baxter International Business Overview and Its Total Revenue
13.1.3 Baxter International General Anaesthesia Drugs Introduction
13.1.4 Baxter International Revenue in General Anaesthesia Drugs Business (2015-2020))
13.1.5 Baxter International Recent Development
13.2 AstraZeneca
13.2.1 AstraZeneca Company Details
13.2.2 AstraZeneca Business Overview and Its Total Revenue
13.2.3 AstraZeneca General Anaesthesia Drugs Introduction
13.2.4 AstraZeneca Revenue in General Anaesthesia Drugs Business (2015-2020)
13.2.5 AstraZeneca Recent Development
13.3 Abbott Laboratories
13.3.1 Abbott Laboratories Company Details
13.3.2 Abbott Laboratories Business Overview and Its Total Revenue
13.3.3 Abbott Laboratories General Anaesthesia Drugs Introduction
13.3.4 Abbott Laboratories Revenue in General Anaesthesia Drugs Business (2015-2020)
13.3.5 Abbott Laboratories Recent Development
13.4 Roche
13.4.1 Roche Company Details
13.4.2 Roche Business Overview and Its Total Revenue
13.4.3 Roche General Anaesthesia Drugs Introduction
13.4.4 Roche Revenue in General Anaesthesia Drugs Business (2015-2020)
13.4.5 Roche Recent Development
13.5 Fresenius
13.5.1 Fresenius Company Details
13.5.2 Fresenius Business Overview and Its Total Revenue
13.5.3 Fresenius General Anaesthesia Drugs Introduction
13.5.4 Fresenius Revenue in General Anaesthesia Drugs Business (2015-2020)
13.5.5 Fresenius Recent Development
13.6 Mylan
13.6.1 Mylan Company Details
13.6.2 Mylan Business Overview and Its Total Revenue
13.6.3 Mylan General Anaesthesia Drugs Introduction
13.6.4 Mylan Revenue in General Anaesthesia Drugs Business (2015-2020)
13.6.5 Mylan Recent Development
13.7 Eisai
13.7.1 Eisai Company Details
13.7.2 Eisai Business Overview and Its Total Revenue
13.7.3 Eisai General Anaesthesia Drugs Introduction
13.7.4 Eisai Revenue in General Anaesthesia Drugs Business (2015-2020)
13.7.5 Eisai Recent Development
13.8 Hospira
13.8.1 Hospira Company Details
13.8.2 Hospira Business Overview and Its Total Revenue
13.8.3 Hospira General Anaesthesia Drugs Introduction
13.8.4 Hospira Revenue in General Anaesthesia Drugs Business (2015-2020)
13.8.5 Hospira Recent Development
13.9 Hikma Pharmaceuticals
13.9.1 Hikma Pharmaceuticals Company Details
13.9.2 Hikma Pharmaceuticals Business Overview and Its Total Revenue
13.9.3 Hikma Pharmaceuticals General Anaesthesia Drugs Introduction
13.9.4 Hikma Pharmaceuticals Revenue in General Anaesthesia Drugs Business (2015-2020)
13.9.5 Hikma Pharmaceuticals Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by General Anaesthesia Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global General Anaesthesia Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Propofol
1.4.3 Sevoflurane
1.4.4 Isoflurane
1.4.5 Dexmedetomidine
1.4.6 Desflurane
1.4.7 Remifentanil
1.4.8 Midazolam
1.4.9 Others
1.5 Market by Application
1.5.1 Global General Anaesthesia Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): General Anaesthesia Drugs Industry Impact
1.6.1 How the Covid-19 is Affecting the General Anaesthesia Drugs Industry
1.6.1.1 General Anaesthesia Drugs Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and General Anaesthesia Drugs Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for General Anaesthesia Drugs Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 General Anaesthesia Drugs Market Perspective (2015-2026)
2.2 General Anaesthesia Drugs Growth Trends by Regions
2.2.1 General Anaesthesia Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 General Anaesthesia Drugs Historic Market Share by Regions (2015-2020)
2.2.3 General Anaesthesia Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 General Anaesthesia Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key General Anaesthesia Drugs Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top General Anaesthesia Drugs Players by Market Size
3.1.1 Global Top General Anaesthesia Drugs Players by Revenue (2015-2020)
3.1.2 Global General Anaesthesia Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global General Anaesthesia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global General Anaesthesia Drugs Market Concentration Ratio
3.2.1 Global General Anaesthesia Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by General Anaesthesia Drugs Revenue in 2019
3.3 General Anaesthesia Drugs Key Players Head office and Area Served
3.4 Key Players General Anaesthesia Drugs Product Solution and Service
3.5 Date of Enter into General Anaesthesia Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global General Anaesthesia Drugs Historic Market Size by Type (2015-2020)
4.2 Global General Anaesthesia Drugs Forecasted Market Size by Type (2021-2026)
5 GENERAL ANAESTHESIA DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global General Anaesthesia Drugs Market Size by Application (2015-2020)
5.2 Global General Anaesthesia Drugs Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America General Anaesthesia Drugs Market Size (2015-2020)
6.2 General Anaesthesia Drugs Key Players in North America (2019-2020)
6.3 North America General Anaesthesia Drugs Market Size by Type (2015-2020)
6.4 North America General Anaesthesia Drugs Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe General Anaesthesia Drugs Market Size (2015-2020)
7.2 General Anaesthesia Drugs Key Players in Europe (2019-2020)
7.3 Europe General Anaesthesia Drugs Market Size by Type (2015-2020)
7.4 Europe General Anaesthesia Drugs Market Size by Application (2015-2020)
8 CHINA
8.1 China General Anaesthesia Drugs Market Size (2015-2020)
8.2 General Anaesthesia Drugs Key Players in China (2019-2020)
8.3 China General Anaesthesia Drugs Market Size by Type (2015-2020)
8.4 China General Anaesthesia Drugs Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan General Anaesthesia Drugs Market Size (2015-2020)
9.2 General Anaesthesia Drugs Key Players in Japan (2019-2020)
9.3 Japan General Anaesthesia Drugs Market Size by Type (2015-2020)
9.4 Japan General Anaesthesia Drugs Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia General Anaesthesia Drugs Market Size (2015-2020)
10.2 General Anaesthesia Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia General Anaesthesia Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia General Anaesthesia Drugs Market Size by Application (2015-2020)
11 INDIA
11.1 India General Anaesthesia Drugs Market Size (2015-2020)
11.2 General Anaesthesia Drugs Key Players in India (2019-2020)
11.3 India General Anaesthesia Drugs Market Size by Type (2015-2020)
11.4 India General Anaesthesia Drugs Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America General Anaesthesia Drugs Market Size (2015-2020)
12.2 General Anaesthesia Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America General Anaesthesia Drugs Market Size by Type (2015-2020)
12.4 Central & South America General Anaesthesia Drugs Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Baxter International
13.1.1 Baxter International Company Details
13.1.2 Baxter International Business Overview and Its Total Revenue
13.1.3 Baxter International General Anaesthesia Drugs Introduction
13.1.4 Baxter International Revenue in General Anaesthesia Drugs Business (2015-2020))
13.1.5 Baxter International Recent Development
13.2 AstraZeneca
13.2.1 AstraZeneca Company Details
13.2.2 AstraZeneca Business Overview and Its Total Revenue
13.2.3 AstraZeneca General Anaesthesia Drugs Introduction
13.2.4 AstraZeneca Revenue in General Anaesthesia Drugs Business (2015-2020)
13.2.5 AstraZeneca Recent Development
13.3 Abbott Laboratories
13.3.1 Abbott Laboratories Company Details
13.3.2 Abbott Laboratories Business Overview and Its Total Revenue
13.3.3 Abbott Laboratories General Anaesthesia Drugs Introduction
13.3.4 Abbott Laboratories Revenue in General Anaesthesia Drugs Business (2015-2020)
13.3.5 Abbott Laboratories Recent Development
13.4 Roche
13.4.1 Roche Company Details
13.4.2 Roche Business Overview and Its Total Revenue
13.4.3 Roche General Anaesthesia Drugs Introduction
13.4.4 Roche Revenue in General Anaesthesia Drugs Business (2015-2020)
13.4.5 Roche Recent Development
13.5 Fresenius
13.5.1 Fresenius Company Details
13.5.2 Fresenius Business Overview and Its Total Revenue
13.5.3 Fresenius General Anaesthesia Drugs Introduction
13.5.4 Fresenius Revenue in General Anaesthesia Drugs Business (2015-2020)
13.5.5 Fresenius Recent Development
13.6 Mylan
13.6.1 Mylan Company Details
13.6.2 Mylan Business Overview and Its Total Revenue
13.6.3 Mylan General Anaesthesia Drugs Introduction
13.6.4 Mylan Revenue in General Anaesthesia Drugs Business (2015-2020)
13.6.5 Mylan Recent Development
13.7 Eisai
13.7.1 Eisai Company Details
13.7.2 Eisai Business Overview and Its Total Revenue
13.7.3 Eisai General Anaesthesia Drugs Introduction
13.7.4 Eisai Revenue in General Anaesthesia Drugs Business (2015-2020)
13.7.5 Eisai Recent Development
13.8 Hospira
13.8.1 Hospira Company Details
13.8.2 Hospira Business Overview and Its Total Revenue
13.8.3 Hospira General Anaesthesia Drugs Introduction
13.8.4 Hospira Revenue in General Anaesthesia Drugs Business (2015-2020)
13.8.5 Hospira Recent Development
13.9 Hikma Pharmaceuticals
13.9.1 Hikma Pharmaceuticals Company Details
13.9.2 Hikma Pharmaceuticals Business Overview and Its Total Revenue
13.9.3 Hikma Pharmaceuticals General Anaesthesia Drugs Introduction
13.9.4 Hikma Pharmaceuticals Revenue in General Anaesthesia Drugs Business (2015-2020)
13.9.5 Hikma Pharmaceuticals Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. General Anaesthesia Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by General Anaesthesia Drugs Revenue
Table 3. Ranking of Global Top General Anaesthesia Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global General Anaesthesia Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Propofol
Table 6. Key Players of Sevoflurane
Table 7. Key Players of Isoflurane
Table 8. Key Players of Dexmedetomidine
Table 9. Key Players of Desflurane
Table 10. Key Players of Remifentanil
Table 11. Key Players of Midazolam
Table 12. Key Players of Others
Table 13. COVID-19 Impact Global Market: (Four General Anaesthesia Drugs Market Size Forecast Scenarios)
Table 14. Opportunities and Trends for General Anaesthesia Drugs Players in the COVID-19 Landscape
Table 15. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 16. Key Regions/Countries Measures against Covid-19 Impact
Table 17. Proposal for General Anaesthesia Drugs Players to Combat Covid-19 Impact
Table 18. Global General Anaesthesia Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 19. Global General Anaesthesia Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 20. Global General Anaesthesia Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 21. Global General Anaesthesia Drugs Market Share by Regions (2015-2020)
Table 22. Global General Anaesthesia Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 23. Global General Anaesthesia Drugs Market Share by Regions (2021-2026)
Table 24. Market Top Trends
Table 25. Key Drivers: Impact Analysis
Table 26. Key Challenges
Table 27. General Anaesthesia Drugs Market Growth Strategy
Table 28. Main Points Interviewed from Key General Anaesthesia Drugs Players
Table 29. Global General Anaesthesia Drugs Revenue by Players (2015-2020) (Million US$)
Table 30. Global General Anaesthesia Drugs Market Share by Players (2015-2020)
Table 31. Global Top General Anaesthesia Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in General Anaesthesia Drugs as of 2019)
Table 32. Global General Anaesthesia Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 33. Key Players Headquarters and Area Served
Table 34. Key Players General Anaesthesia Drugs Product Solution and Service
Table 35. Date of Enter into General Anaesthesia Drugs Market
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global General Anaesthesia Drugs Market Size by Type (2015-2020) (Million US$)
Table 38. Global General Anaesthesia Drugs Market Size Share by Type (2015-2020)
Table 39. Global General Anaesthesia Drugs Revenue Market Share by Type (2021-2026)
Table 40. Global General Anaesthesia Drugs Market Size Share by Application (2015-2020)
Table 41. Global General Anaesthesia Drugs Market Size by Application (2015-2020) (Million US$)
Table 42. Global General Anaesthesia Drugs Market Size Share by Application (2021-2026)
Table 43. North America Key Players General Anaesthesia Drugs Revenue (2019-2020) (Million US$)
Table 44. North America Key Players General Anaesthesia Drugs Market Share (2019-2020)
Table 45. North America General Anaesthesia Drugs Market Size by Type (2015-2020) (Million US$)
Table 46. North America General Anaesthesia Drugs Market Share by Type (2015-2020)
Table 47. North America General Anaesthesia Drugs Market Size by Application (2015-2020) (Million US$)
Table 48. North America General Anaesthesia Drugs Market Share by Application (2015-2020)
Table 49. Europe Key Players General Anaesthesia Drugs Revenue (2019-2020) (Million US$)
Table 50. Europe Key Players General Anaesthesia Drugs Market Share (2019-2020)
Table 51. Europe General Anaesthesia Drugs Market Size by Type (2015-2020) (Million US$)
Table 52. Europe General Anaesthesia Drugs Market Share by Type (2015-2020)
Table 53. Europe General Anaesthesia Drugs Market Size by Application (2015-2020) (Million US$)
Table 54. Europe General Anaesthesia Drugs Market Share by Application (2015-2020)
Table 55. China Key Players General Anaesthesia Drugs Revenue (2019-2020) (Million US$)
Table 56. China Key Players General Anaesthesia Drugs Market Share (2019-2020)
Table 57. China General Anaesthesia Drugs Market Size by Type (2015-2020) (Million US$)
Table 58. China General Anaesthesia Drugs Market Share by Type (2015-2020)
Table 59. China General Anaesthesia Drugs Market Size by Application (2015-2020) (Million US$)
Table 60. China General Anaesthesia Drugs Market Share by Application (2015-2020)
Table 61. Japan Key Players General Anaesthesia Drugs Revenue (2019-2020) (Million US$)
Table 62. Japan Key Players General Anaesthesia Drugs Market Share (2019-2020)
Table 63. Japan General Anaesthesia Drugs Market Size by Type (2015-2020) (Million US$)
Table 64. Japan General Anaesthesia Drugs Market Share by Type (2015-2020)
Table 65. Japan General Anaesthesia Drugs Market Size by Application (2015-2020) (Million US$)
Table 66. Japan General Anaesthesia Drugs Market Share by Application (2015-2020)
Table 67. Southeast Asia Key Players General Anaesthesia Drugs Revenue (2019-2020) (Million US$)
Table 68. Southeast Asia Key Players General Anaesthesia Drugs Market Share (2019-2020)
Table 69. Southeast Asia General Anaesthesia Drugs Market Size by Type (2015-2020) (Million US$)
Table 70. Southeast Asia General Anaesthesia Drugs Market Share by Type (2015-2020)
Table 71. Southeast Asia General Anaesthesia Drugs Market Size by Application (2015-2020) (Million US$)
Table 72. Southeast Asia General Anaesthesia Drugs Market Share by Application (2015-2020)
Table 73. India Key Players General Anaesthesia Drugs Revenue (2019-2020) (Million US$)
Table 74. India Key Players General Anaesthesia Drugs Market Share (2019-2020)
Table 75. India General Anaesthesia Drugs Market Size by Type (2015-2020) (Million US$)
Table 76. India General Anaesthesia Drugs Market Share by Type (2015-2020)
Table 77. India General Anaesthesia Drugs Market Size by Application (2015-2020) (Million US$)
Table 78. India General Anaesthesia Drugs Market Share by Application (2015-2020)
Table 79. Central & South America Key Players General Anaesthesia Drugs Revenue (2019-2020) (Million US$)
Table 80. Central & South America Key Players General Anaesthesia Drugs Market Share (2019-2020)
Table 81. Central & South America General Anaesthesia Drugs Market Size by Type (2015-2020) (Million US$)
Table 82. Central & South America General Anaesthesia Drugs Market Share by Type (2015-2020)
Table 83. Central & South America General Anaesthesia Drugs Market Size by Application (2015-2020) (Million US$)
Table 84. Central & South America General Anaesthesia Drugs Market Share by Application (2015-2020)
Table 85. Baxter International Company Details
Table 86. Baxter International Business Overview
Table 87. Baxter International Product
Table 88. Baxter International Revenue in General Anaesthesia Drugs Business (2015-2020) (Million US$)
Table 89. Baxter International Recent Development
Table 90. AstraZeneca Company Details
Table 91. AstraZeneca Business Overview
Table 92. AstraZeneca Product
Table 93. AstraZeneca Revenue in General Anaesthesia Drugs Business (2015-2020) (Million US$)
Table 94. AstraZeneca Recent Development
Table 95. Abbott Laboratories Company Details
Table 96. Abbott Laboratories Business Overview
Table 97. Abbott Laboratories Product
Table 98. Abbott Laboratories Revenue in General Anaesthesia Drugs Business (2015-2020) (Million US$)
Table 99. Abbott Laboratories Recent Development
Table 100. Roche Company Details
Table 101. Roche Business Overview
Table 102. Roche Product
Table 103. Roche Revenue in General Anaesthesia Drugs Business (2015-2020) (Million US$)
Table 104. Roche Recent Development
Table 105. Fresenius Company Details
Table 106. Fresenius Business Overview
Table 107. Fresenius Product
Table 108. Fresenius Revenue in General Anaesthesia Drugs Business (2015-2020) (Million US$)
Table 109. Fresenius Recent Development
Table 110. Mylan Company Details
Table 111. Mylan Business Overview
Table 112. Mylan Product
Table 113. Mylan Revenue in General Anaesthesia Drugs Business (2015-2020) (Million US$)
Table 114. Mylan Recent Development
Table 115. Eisai Company Details
Table 116. Eisai Business Overview
Table 117. Eisai Product
Table 118. Eisai Revenue in General Anaesthesia Drugs Business (2015-2020) (Million US$)
Table 119. Eisai Recent Development
Table 120. Hospira Business Overview
Table 121. Hospira Product
Table 122. Hospira Company Details
Table 123. Hospira Revenue in General Anaesthesia Drugs Business (2015-2020) (Million US$)
Table 124. Hospira Recent Development
Table 125. Hikma Pharmaceuticals Company Details
Table 126. Hikma Pharmaceuticals Business Overview
Table 127. Hikma Pharmaceuticals Product
Table 128. Hikma Pharmaceuticals Revenue in General Anaesthesia Drugs Business (2015-2020) (Million US$)
Table 129. Hikma Pharmaceuticals Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
Table 1. General Anaesthesia Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by General Anaesthesia Drugs Revenue
Table 3. Ranking of Global Top General Anaesthesia Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global General Anaesthesia Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Propofol
Table 6. Key Players of Sevoflurane
Table 7. Key Players of Isoflurane
Table 8. Key Players of Dexmedetomidine
Table 9. Key Players of Desflurane
Table 10. Key Players of Remifentanil
Table 11. Key Players of Midazolam
Table 12. Key Players of Others
Table 13. COVID-19 Impact Global Market: (Four General Anaesthesia Drugs Market Size Forecast Scenarios)
Table 14. Opportunities and Trends for General Anaesthesia Drugs Players in the COVID-19 Landscape
Table 15. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 16. Key Regions/Countries Measures against Covid-19 Impact
Table 17. Proposal for General Anaesthesia Drugs Players to Combat Covid-19 Impact
Table 18. Global General Anaesthesia Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 19. Global General Anaesthesia Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 20. Global General Anaesthesia Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 21. Global General Anaesthesia Drugs Market Share by Regions (2015-2020)
Table 22. Global General Anaesthesia Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 23. Global General Anaesthesia Drugs Market Share by Regions (2021-2026)
Table 24. Market Top Trends
Table 25. Key Drivers: Impact Analysis
Table 26. Key Challenges
Table 27. General Anaesthesia Drugs Market Growth Strategy
Table 28. Main Points Interviewed from Key General Anaesthesia Drugs Players
Table 29. Global General Anaesthesia Drugs Revenue by Players (2015-2020) (Million US$)
Table 30. Global General Anaesthesia Drugs Market Share by Players (2015-2020)
Table 31. Global Top General Anaesthesia Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in General Anaesthesia Drugs as of 2019)
Table 32. Global General Anaesthesia Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 33. Key Players Headquarters and Area Served
Table 34. Key Players General Anaesthesia Drugs Product Solution and Service
Table 35. Date of Enter into General Anaesthesia Drugs Market
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global General Anaesthesia Drugs Market Size by Type (2015-2020) (Million US$)
Table 38. Global General Anaesthesia Drugs Market Size Share by Type (2015-2020)
Table 39. Global General Anaesthesia Drugs Revenue Market Share by Type (2021-2026)
Table 40. Global General Anaesthesia Drugs Market Size Share by Application (2015-2020)
Table 41. Global General Anaesthesia Drugs Market Size by Application (2015-2020) (Million US$)
Table 42. Global General Anaesthesia Drugs Market Size Share by Application (2021-2026)
Table 43. North America Key Players General Anaesthesia Drugs Revenue (2019-2020) (Million US$)
Table 44. North America Key Players General Anaesthesia Drugs Market Share (2019-2020)
Table 45. North America General Anaesthesia Drugs Market Size by Type (2015-2020) (Million US$)
Table 46. North America General Anaesthesia Drugs Market Share by Type (2015-2020)
Table 47. North America General Anaesthesia Drugs Market Size by Application (2015-2020) (Million US$)
Table 48. North America General Anaesthesia Drugs Market Share by Application (2015-2020)
Table 49. Europe Key Players General Anaesthesia Drugs Revenue (2019-2020) (Million US$)
Table 50. Europe Key Players General Anaesthesia Drugs Market Share (2019-2020)
Table 51. Europe General Anaesthesia Drugs Market Size by Type (2015-2020) (Million US$)
Table 52. Europe General Anaesthesia Drugs Market Share by Type (2015-2020)
Table 53. Europe General Anaesthesia Drugs Market Size by Application (2015-2020) (Million US$)
Table 54. Europe General Anaesthesia Drugs Market Share by Application (2015-2020)
Table 55. China Key Players General Anaesthesia Drugs Revenue (2019-2020) (Million US$)
Table 56. China Key Players General Anaesthesia Drugs Market Share (2019-2020)
Table 57. China General Anaesthesia Drugs Market Size by Type (2015-2020) (Million US$)
Table 58. China General Anaesthesia Drugs Market Share by Type (2015-2020)
Table 59. China General Anaesthesia Drugs Market Size by Application (2015-2020) (Million US$)
Table 60. China General Anaesthesia Drugs Market Share by Application (2015-2020)
Table 61. Japan Key Players General Anaesthesia Drugs Revenue (2019-2020) (Million US$)
Table 62. Japan Key Players General Anaesthesia Drugs Market Share (2019-2020)
Table 63. Japan General Anaesthesia Drugs Market Size by Type (2015-2020) (Million US$)
Table 64. Japan General Anaesthesia Drugs Market Share by Type (2015-2020)
Table 65. Japan General Anaesthesia Drugs Market Size by Application (2015-2020) (Million US$)
Table 66. Japan General Anaesthesia Drugs Market Share by Application (2015-2020)
Table 67. Southeast Asia Key Players General Anaesthesia Drugs Revenue (2019-2020) (Million US$)
Table 68. Southeast Asia Key Players General Anaesthesia Drugs Market Share (2019-2020)
Table 69. Southeast Asia General Anaesthesia Drugs Market Size by Type (2015-2020) (Million US$)
Table 70. Southeast Asia General Anaesthesia Drugs Market Share by Type (2015-2020)
Table 71. Southeast Asia General Anaesthesia Drugs Market Size by Application (2015-2020) (Million US$)
Table 72. Southeast Asia General Anaesthesia Drugs Market Share by Application (2015-2020)
Table 73. India Key Players General Anaesthesia Drugs Revenue (2019-2020) (Million US$)
Table 74. India Key Players General Anaesthesia Drugs Market Share (2019-2020)
Table 75. India General Anaesthesia Drugs Market Size by Type (2015-2020) (Million US$)
Table 76. India General Anaesthesia Drugs Market Share by Type (2015-2020)
Table 77. India General Anaesthesia Drugs Market Size by Application (2015-2020) (Million US$)
Table 78. India General Anaesthesia Drugs Market Share by Application (2015-2020)
Table 79. Central & South America Key Players General Anaesthesia Drugs Revenue (2019-2020) (Million US$)
Table 80. Central & South America Key Players General Anaesthesia Drugs Market Share (2019-2020)
Table 81. Central & South America General Anaesthesia Drugs Market Size by Type (2015-2020) (Million US$)
Table 82. Central & South America General Anaesthesia Drugs Market Share by Type (2015-2020)
Table 83. Central & South America General Anaesthesia Drugs Market Size by Application (2015-2020) (Million US$)
Table 84. Central & South America General Anaesthesia Drugs Market Share by Application (2015-2020)
Table 85. Baxter International Company Details
Table 86. Baxter International Business Overview
Table 87. Baxter International Product
Table 88. Baxter International Revenue in General Anaesthesia Drugs Business (2015-2020) (Million US$)
Table 89. Baxter International Recent Development
Table 90. AstraZeneca Company Details
Table 91. AstraZeneca Business Overview
Table 92. AstraZeneca Product
Table 93. AstraZeneca Revenue in General Anaesthesia Drugs Business (2015-2020) (Million US$)
Table 94. AstraZeneca Recent Development
Table 95. Abbott Laboratories Company Details
Table 96. Abbott Laboratories Business Overview
Table 97. Abbott Laboratories Product
Table 98. Abbott Laboratories Revenue in General Anaesthesia Drugs Business (2015-2020) (Million US$)
Table 99. Abbott Laboratories Recent Development
Table 100. Roche Company Details
Table 101. Roche Business Overview
Table 102. Roche Product
Table 103. Roche Revenue in General Anaesthesia Drugs Business (2015-2020) (Million US$)
Table 104. Roche Recent Development
Table 105. Fresenius Company Details
Table 106. Fresenius Business Overview
Table 107. Fresenius Product
Table 108. Fresenius Revenue in General Anaesthesia Drugs Business (2015-2020) (Million US$)
Table 109. Fresenius Recent Development
Table 110. Mylan Company Details
Table 111. Mylan Business Overview
Table 112. Mylan Product
Table 113. Mylan Revenue in General Anaesthesia Drugs Business (2015-2020) (Million US$)
Table 114. Mylan Recent Development
Table 115. Eisai Company Details
Table 116. Eisai Business Overview
Table 117. Eisai Product
Table 118. Eisai Revenue in General Anaesthesia Drugs Business (2015-2020) (Million US$)
Table 119. Eisai Recent Development
Table 120. Hospira Business Overview
Table 121. Hospira Product
Table 122. Hospira Company Details
Table 123. Hospira Revenue in General Anaesthesia Drugs Business (2015-2020) (Million US$)
Table 124. Hospira Recent Development
Table 125. Hikma Pharmaceuticals Company Details
Table 126. Hikma Pharmaceuticals Business Overview
Table 127. Hikma Pharmaceuticals Product
Table 128. Hikma Pharmaceuticals Revenue in General Anaesthesia Drugs Business (2015-2020) (Million US$)
Table 129. Hikma Pharmaceuticals Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global General Anaesthesia Drugs Market Share by Type: 2020 VS 2026
Figure 2. Propofol Features
Figure 3. Sevoflurane Features
Figure 4. Isoflurane Features
Figure 5. Dexmedetomidine Features
Figure 6. Desflurane Features
Figure 7. Remifentanil Features
Figure 8. Midazolam Features
Figure 9. Others Features
Figure 10. Global General Anaesthesia Drugs Market Share by Application: 2020 VS 2026
Figure 11. Hospitals Case Studies
Figure 12. Clinics Case Studies
Figure 13. Others Case Studies
Figure 14. General Anaesthesia Drugs Report Years Considered
Figure 15. Global General Anaesthesia Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global General Anaesthesia Drugs Market Share by Regions: 2020 VS 2026
Figure 17. Global General Anaesthesia Drugs Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global General Anaesthesia Drugs Market Share by Players in 2019
Figure 20. Global Top General Anaesthesia Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in General Anaesthesia Drugs as of 2019
Figure 21. The Top 10 and 5 Players Market Share by General Anaesthesia Drugs Revenue in 2019
Figure 22. North America General Anaesthesia Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe General Anaesthesia Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China General Anaesthesia Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan General Anaesthesia Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia General Anaesthesia Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India General Anaesthesia Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America General Anaesthesia Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Baxter International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Baxter International Revenue Growth Rate in General Anaesthesia Drugs Business (2015-2020)
Figure 31. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. AstraZeneca Revenue Growth Rate in General Anaesthesia Drugs Business (2015-2020)
Figure 33. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Abbott Laboratories Revenue Growth Rate in General Anaesthesia Drugs Business (2015-2020)
Figure 35. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Roche Revenue Growth Rate in General Anaesthesia Drugs Business (2015-2020)
Figure 37. Fresenius Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Fresenius Revenue Growth Rate in General Anaesthesia Drugs Business (2015-2020)
Figure 39. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Mylan Revenue Growth Rate in General Anaesthesia Drugs Business (2015-2020)
Figure 41. Eisai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Eisai Revenue Growth Rate in General Anaesthesia Drugs Business (2015-2020)
Figure 43. Hospira Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Hospira Revenue Growth Rate in General Anaesthesia Drugs Business (2015-2020)
Figure 45. Hikma Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Hikma Pharmaceuticals Revenue Growth Rate in General Anaesthesia Drugs Business (2015-2020)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed
Figure 1. Global General Anaesthesia Drugs Market Share by Type: 2020 VS 2026
Figure 2. Propofol Features
Figure 3. Sevoflurane Features
Figure 4. Isoflurane Features
Figure 5. Dexmedetomidine Features
Figure 6. Desflurane Features
Figure 7. Remifentanil Features
Figure 8. Midazolam Features
Figure 9. Others Features
Figure 10. Global General Anaesthesia Drugs Market Share by Application: 2020 VS 2026
Figure 11. Hospitals Case Studies
Figure 12. Clinics Case Studies
Figure 13. Others Case Studies
Figure 14. General Anaesthesia Drugs Report Years Considered
Figure 15. Global General Anaesthesia Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global General Anaesthesia Drugs Market Share by Regions: 2020 VS 2026
Figure 17. Global General Anaesthesia Drugs Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global General Anaesthesia Drugs Market Share by Players in 2019
Figure 20. Global Top General Anaesthesia Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in General Anaesthesia Drugs as of 2019
Figure 21. The Top 10 and 5 Players Market Share by General Anaesthesia Drugs Revenue in 2019
Figure 22. North America General Anaesthesia Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe General Anaesthesia Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China General Anaesthesia Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan General Anaesthesia Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia General Anaesthesia Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India General Anaesthesia Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America General Anaesthesia Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Baxter International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Baxter International Revenue Growth Rate in General Anaesthesia Drugs Business (2015-2020)
Figure 31. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. AstraZeneca Revenue Growth Rate in General Anaesthesia Drugs Business (2015-2020)
Figure 33. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Abbott Laboratories Revenue Growth Rate in General Anaesthesia Drugs Business (2015-2020)
Figure 35. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Roche Revenue Growth Rate in General Anaesthesia Drugs Business (2015-2020)
Figure 37. Fresenius Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Fresenius Revenue Growth Rate in General Anaesthesia Drugs Business (2015-2020)
Figure 39. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Mylan Revenue Growth Rate in General Anaesthesia Drugs Business (2015-2020)
Figure 41. Eisai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Eisai Revenue Growth Rate in General Anaesthesia Drugs Business (2015-2020)
Figure 43. Hospira Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Hospira Revenue Growth Rate in General Anaesthesia Drugs Business (2015-2020)
Figure 45. Hikma Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Hikma Pharmaceuticals Revenue Growth Rate in General Anaesthesia Drugs Business (2015-2020)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed